Conduct research to understand the epidemiology of thromboembolism after cancer diagnosis and identify the contributing factors. Thromboembolism can cause treatment dilemma as many anticancer treatments cause thrombocytopenia. Better understanding of the timing and risk factors can provide evidence-based management of cancer patients without the risks of life threatening bleeding or thromboembolism. Possible risk factors include, but not limited to, cancer type, anticancer therapy, and stress.
Idea No. 400